MAPK1 and acute lymphoblastic leukemia: Moreover, downregulation of miR-335 seems to decrease the sensitivity of ALL cells to prednisone (by enhancing its target MAPK1), whereas treatment with Ras-Raf-MEK-ERK pathway inhibitors can activate BIM and promote prednisolone-induced cell death [112,138].